Epstein-Barr virus and wild p53 in idiopathic pulmonary fibrosis
- PMID: 11601742
- DOI: 10.1053/rmed.2001.1152
Epstein-Barr virus and wild p53 in idiopathic pulmonary fibrosis
Abstract
Both Epstein-Barr virus (EBV) and p53 have independently been associated with idiopathic pulmonary fibrosis (IPF). This study explores further whether a relationship potentially exists between EBV and p53 in IPF, thereby providing a possible mechanism for the role of EBV in the disease progression of IPF. Lung tissue from open lung biopsies of 14 IPF patients was compared with a control group of 19 patients. EBV status was determined using both immunohistochemistry and PCR, while p53 expression was assessed with immunohistochemistry Seven of 14 IPF patients expressed p53 compared to one of 19 control subjects (P = 0.011). Eight IPF patients and no controls were positive for EBV (P < 0.01). Four IPF patients demonstrated both EBVand p53 expression compared with no controls, (P = 0.05). This study suggests that a relationship between EBV and p53 may exist in patients with IPF.
Similar articles
-
The detection of Epstein-Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis.Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 1):1336-41. doi: 10.1164/ajrccm.159.4.9807077. Am J Respir Crit Care Med. 1999. PMID: 10194186
-
Expression and alteration of ras and p53 proteins in patients with lung carcinoma accompanied by idiopathic pulmonary fibrosis.Cancer. 2002 Aug 1;95(3):624-33. doi: 10.1002/cncr.10708. Cancer. 2002. PMID: 12209756
-
A novel screening method detects herpesviral DNA in the idiopathic pulmonary fibrosis lung.Ann Med. 2012 Mar;44(2):178-86. doi: 10.3109/07853890.2010.532151. Epub 2011 Jan 24. Ann Med. 2012. PMID: 21254895
-
Gammaherpesviruses and pulmonary fibrosis: evidence from humans, horses, and rodents.Vet Pathol. 2014 Mar;51(2):372-84. doi: 10.1177/0300985814521838. Vet Pathol. 2014. PMID: 24569614 Review.
-
Viruses in Idiopathic Pulmonary Fibrosis. Etiology and Exacerbation.Ann Am Thorac Soc. 2015 Nov;12 Suppl 2(Suppl 2):S186-92. doi: 10.1513/AnnalsATS.201502-088AW. Ann Am Thorac Soc. 2015. PMID: 26595738 Free PMC article. Review.
Cited by
-
Perspectives of PDE inhibitor on treating idiopathic pulmonary fibrosis.Front Pharmacol. 2023 Feb 14;14:1111393. doi: 10.3389/fphar.2023.1111393. eCollection 2023. Front Pharmacol. 2023. PMID: 36865908 Free PMC article. Review.
-
TLR9-induced interferon β is associated with protection from gammaherpesvirus-induced exacerbation of lung fibrosis.Fibrogenesis Tissue Repair. 2011 Aug 2;4:18. doi: 10.1186/1755-1536-4-18. Fibrogenesis Tissue Repair. 2011. PMID: 21810214 Free PMC article.
-
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824. doi: 10.1164/rccm.2009-040GL. Am J Respir Crit Care Med. 2011. PMID: 21471066 Free PMC article.
-
Role of innate immune system in systemic sclerosis.Semin Immunopathol. 2015 Sep;37(5):511-7. doi: 10.1007/s00281-015-0503-7. Epub 2015 Jul 10. Semin Immunopathol. 2015. PMID: 26159672 Review.
-
Determinants of initiation and progression of idiopathic pulmonary fibrosis.Respirology. 2009 Sep;14(7):917-33. doi: 10.1111/j.1440-1843.2009.01624.x. Respirology. 2009. PMID: 19740254 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous